Charles Schwab’s Pulse Biosciences PLSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.21M | Buy |
151,991
+4,223
| +3% | +$99.7K | ﹤0.01% | 2546 |
|
|
2026
Q1 | $3.19M | Sell |
147,768
-4,652
| -3% | -$85.9K | ﹤0.01% | 2584 |
|
|
2025
Q4 | $2.09M | Sell |
152,420
-238
| -0.2% | -$3.71K | ﹤0.01% | 2747 |
|
|
2025
Q3 | $2.7M | Sell |
152,658
-19,749
| -11% | -$312K | ﹤0.01% | 2678 |
|
|
2025
Q2 | $2.6M | Buy |
172,407
+22,768
| +15% | +$378K | ﹤0.01% | 2592 |
|
|
2025
Q1 | $2.41M | Buy |
149,639
+433
| +0.3% | +$8.07K | ﹤0.01% | 2554 |
|
|
2024
Q4 | $2.6M | Buy |
149,206
+1,092
| +0.7% | +$19.3K | ﹤0.01% | 2600 |
|
|
2024
Q3 | $2.6M | Buy |
148,114
+97,565
| +193% | +$1.66M | ﹤0.01% | 2627 |
|
|
2024
Q2 | $566K | Buy |
50,549
+6,854
| +16% | +$64.6K | ﹤0.01% | 3144 |
|
|
2024
Q1 | $381K | Hold |
43,695
| – | – | ﹤0.01% | 3122 |
|
|
2023
Q4 | $535K | Hold |
43,695
| – | – | ﹤0.01% | 3056 |
|
|
2023
Q3 | $176K | Hold |
43,695
| – | – | ﹤0.01% | 3307 |
|
|
2023
Q2 | $314K | Buy |
+43,695
| New | +$279K | ﹤0.01% | 3216 |
|
|
2022
Q2 | – | Sell |
-30,780
| Closed | -$150K | – | 3621 |
|
|
2022
Q1 | $150K | Sell |
30,780
-5,314
| -15% | -$43.5K | ﹤0.01% | 3357 |
|
|
2021
Q4 | $535K | Buy |
36,094
+1,540
| +4% | +$30.7K | ﹤0.01% | 3122 |
|
|
2021
Q3 | $747K | Sell |
34,554
-258
| -0.7% | -$5.55K | ﹤0.01% | 2991 |
|
|
2021
Q2 | $571K | Sell |
34,812
-814
| -2% | -$15.5K | ﹤0.01% | 3121 |
|
|
2021
Q1 | $844K | Buy |
35,626
+2,018
| +6% | +$60.3K | ﹤0.01% | 2908 |
|
|
2020
Q4 | $802K | Buy |
33,608
+2,406
| +8% | +$38.3K | ﹤0.01% | 2837 |
|
|
2020
Q3 | $368K | Sell |
31,202
-1,732
| -5% | -$18.6K | ﹤0.01% | 2968 |
|
|
2020
Q2 | $345K | Buy |
32,934
+5,941
| +22% | +$53.5K | ﹤0.01% | 2980 |
|
|
2020
Q1 | $194K | Hold |
26,993
| – | – | ﹤0.01% | 3017 |
|
|
2019
Q4 | $362K | Hold |
26,993
| – | – | ﹤0.01% | 2931 |
|
|
2019
Q3 | $417K | Hold |
26,993
| – | – | ﹤0.01% | 2874 |
|
|
2019
Q2 | $357K | Buy |
26,993
+1,853
| +7% | +$25.3K | ﹤0.01% | 2961 |
|
|
2019
Q1 | $443K | Buy |
25,140
+2,240
| +10% | +$35.1K | ﹤0.01% | 2800 |
|
|
2018
Q4 | $263K | Buy |
22,900
+3,000
| +15% | +$36.3K | ﹤0.01% | 2973 |
|
|
2018
Q3 | $283K | Buy |
19,900
+4,500
| +29% | +$63.9K | ﹤0.01% | 3017 |
|
|
2018
Q2 | $234K | Buy |
15,400
+100
| +0.7% | +$1.69K | ﹤0.01% | 3043 |
|
|
2018
Q1 | $208K | Hold |
15,300
| – | – | ﹤0.01% | 2981 |
|
|
2017
Q4 | $362K | Hold |
15,300
| – | – | ﹤0.01% | 2818 |
|
|
2017
Q3 | $285K | Hold |
15,300
| – | – | ﹤0.01% | 2892 |
|
|
2017
Q2 | $529K | Buy |
+15,300
| New | +$421K | ﹤0.01% | 2672 |
|
Other funds holding PLSE
PCM
Charles Schwab's PLSE Position: Q2 2026 in Review
Charles Schwab increased its Pulse Biosciences (PLSE) stake by 2.9% in Q2 2026, buying an estimated $99.7K and bringing the position to 151,991 shares worth $4.21M. The position accounts for ﹤0.01% of the portfolio, ranked #2546.
Charles Schwab first reported a position in PLSE in Q2 2017 and has held it in 33 quarters since. 106 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.
- Charles Schwab held 151,991 shares of Pulse Biosciences worth $4.21M as of Q2 2026.
- Charles Schwab bought 4,223 Pulse Biosciences shares in Q2 2026, an estimated $99.7K.
- Pulse Biosciences made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #2546 holding.
- Charles Schwab first reported a position in Pulse Biosciences in Q2 2017 and has held it in 33 quarters since.
- 106 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.